logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

EBCC 2018 - Even women with aggressive tumours can be safely treated with breast-preserving surgery if their cancer responds to targeted treatment

Pretreatment with targeted drugs may safely spare extensive surgery in HER2 positive breast cancer